<s id="srsen"><object id="srsen"><blockquote id="srsen"></blockquote></object></s>

  • <tbody id="srsen"></tbody>

      <rp id="srsen"></rp>
      <dd id="srsen"></dd>
    1. <rp id="srsen"></rp>
    2. NeoMab? Fully-Human Antibody Dicovery

      Antibody Drug Discovery

      NeoMab Bio, a subsidiary company of Gempharmatech, has established a comprehensive antibody discovery platform by integrating its self-developed fully-human antibody transgenic mice NeoMab? and over 20 years of in-vivo/in-vitro experimental experience. It provides innovative technological platforms and reliable technical services for antibody drug discovery. 


      • Our Advantages

      (1) NeoMab? has a better immune response to different categories of immunogens, resulting in high antibody diversity; 

      (2) High diversity of antibody molecules to meet the needs of different types of antibody discovery;

      (4) Customized services to meet the needs of different customers; 

      (5) Integrated resources to provide efficient early antibody drug discovery services.


      • Our Services

      Based on the fully human antibody transgenic mouse NeoMab?, NeoMab Bio can provide services run through the whole process of antibody discovery.

      (1) Project design; 

      (2) Material preparation; 

      (3) Immunization; 

      (4) Molecular generation and screening; 

      (5) In-vivo and in-vitro functional verification.


      Learn MORE About Antibody Fully-Humanized Mouse Models.


      GemPharmatech is committed to protecting and respecting your privacy, and we'll only use your personal information to administer your account and to provide the products and services you requested from us. From time to time, we would like to contact you about our products and services, as well as other content that may be of interest to you. If you consent to us contacting you for this purpose, please click below to say how you would like us to contact you:

      In order to provide you with the content requested, we need to store and process your personal data. If you consent to us storing your personal data for this purpose, please click the checkbox below.

      You can unsubscribe from these communications at any time. For more information on how to unsubscribe, our privacy practices, and how we are committed to protecting and respecting your privacy, please review our Privacy Policy.